Navigation Links
MainConcept Releases New Codec SDK 8.0

Full AVC-Intra encoding, 64-bit support, seamless integration and improved quality benefit a wide range of industries

AACHEN, Germany, Feb. 10 /PRNewswire/ -- MainConcept GmbH, a wholly-owned subsidiary of DivX, Inc. (Nasdaq: DIVX) and one of the world's leading providers of video/audio codecs and software development kits (SDKs) to the broadcast, film and consumer markets, today announced the release of Codec SDK 8.0 with seamless integration and higher performance. This comprehensive package of industry leading codecs offers enhanced value such as 64-bit support and full AVC-Intra encoding to a wide range of industries including professional broadcast, healthcare, video-conferencing, surveillance, and consumer electronics.


Using the new Codec SDK 8.0, professional software developers can seamlessly integrate low level codec components and DirectShow filters for video, as well as audio encode and decode into their own solutions, thereby increasing the number of platforms. This allows developers to reduce integration work, save time and decrease costs, while increasing the overall solution quality since the same line of code is utilized.

In addition, all components for the Codec SDK 8.0 are available as 32-bit and 64-bit versions for Windows, Mac OS X (Intel) and Linux. A 64-bit SDK 8.0 for Mac OS X (Intel) and the MainConcept(TM) Reference SDK with the full feature set will be available for licensing soon.

Full AVC-Intra 100/AVC-Intra 50 support is included in the SDK 8.0. Now available is a low delay flag to reduce latency, an essential feature for video-conferencing, as well as medical and security software using the H.264/AVC format. The H.264 and the MPEG-2 component for encoding have been optimized for improved quality.

Codec SDK 8.0 offers enhanced support for:

  • Panasonic AVC-Intra 100/AVC-Intra 50
  • Digital Cinema (DCI 2K, DCI 4K)
  • DXVA GPU Hardware Acceleration for H.264 and MPEG-2

"Industry leading companies worldwide rely on our Codec SDK and will immediately benefit from the tremendous technical improvements we have made," said Muzaffer Beygirci, Managing Director and Vice President Worldwide Sales at MainConcept. "With this new SDK version, we continue to deliver on our mission to make every codec available for every major platform."

The full feature list of the new Codec SDK 8.0 and all supported codecs is available at For existing customers and partners with a maintenance contract, the product release will be available at MainConcept's Customer Portal for immediate download. Other parties interested in evaluating MainConcept Codec SDK 8.0 may send an e-mail to sales(at) to request an evaluation license.

About MainConcept

MainConcept is one of the world's leading providers of high-quality codec technology for the broadcast, film, consumer electronics, computer software, medical imaging and security markets, among others. MainConcept solutions are optimized for various platforms including PCs, set-top boxes, portable media players and mobile phones, supporting the most popular industry standards such as MPEG-2, MPEG-4 Part 2, H.264/AVC, VC-1, DV, DVCPRO, DVCPRO HD, JPEG2000, AAC, HE-AAC and AC3. MainConcept is headquartered in Germany with subsidiaries in the USA, Russia, and Japan. The company serves the Asia-Pacific region through key distribution partners in China, Korea, and Taiwan. Customers include some of the most respected international companies including Adobe, Leitch/Harris, Microsoft, mobiTV, Sonic Solutions, Sony, and Panasonic. MainConcept is a wholly owned subsidiary of DivX, Inc. (Nasdaq: DIVX). For more information and available codecs visit Parties interested in licensing MainConcept technology can contact the company at

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, statements regarding DivX's visibility within the investment community. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause DivX's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to: the risk that customer use of DivX(R) or MainConcept technologies may not grow as anticipated; the risk that anticipated market opportunities may not materialize at expected levels, or at all; the risk that the Company's activities may not result in the growth of profitable revenue; risks and uncertainties related to the maintenance and strength of the DivX and MainConcept brand; risks associated with DivX and MainConcept's ability to penetrate existing and new markets; risks regarding the effects of competition; the risk of DivX and MainConcept's dependence on its licensees and partners; risks related to the effect of intellectual property rights claims; and other factors discussed in the "Risk Factors" section of DivX's most recent report filed with the Securities and Exchange Commission. All forward-looking statements are qualified in their entirety by this cautionary statement. DivX is providing this information as of the date of this release and does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. All trademarks are the property of their owners and are used for informational purposes only.

SOURCE MainConcept
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
2. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
3. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
4. Verdict One Releases Directory of Board Certified Attorneys for Consumers
5. Academy releases emergency preparedness tools to enable millions more people to shelter in place
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. MITEM Releases Blue Iris eLaborate 8.6
8. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
9. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
10. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
11. Cardiac Science Releases New Cardiac Rehabilitation System
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... limb amputations in the United States. Podiatrists are well aware that psychology-based patient ... therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... 01, 2015 , ... PartnerTech , a leader in ... since 2008. Gary Bruce, President of PartnerTech North America, currently serves as Director ... amount of time in Sweden since joining PartnerTech based in Malmo, Sweden. He ...
(Date:12/1/2015)... ... 2015 , ... SonaCare Medical congratulates the University College London ... on November 18th. This prestigious award recognizes annually organizations that cultivate truly innovative ... medical landscape. , The UCLH team won the award for their innovative approach ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached its enrollment target of 400 ... trial of aldoxorubicin in patients with previously treated soft ... in Q1 2016. The Phase 3 trial is a randomized, ... from the FDA at 79 sites in ...
(Date:12/1/2015)... 2015  The migration to value-based care will ... plans that help patients stay healthy and reduce ... digitally enabled, incorporate care guidelines and be reflective ... will also allow all stakeholders to collaborate across ... optimal. That is the vision, however, research by ...
(Date:12/1/2015)... -- --> --> ... (NKI-AVL), among the world,s largest and most prestigious ... Icon™, the company,s latest generation stereotactic radiosurgery system ... --> With the option to use ... Knife Icon offers greatly enhanced flexibility in how ...
Breaking Medicine Technology: